Synthetic biology in Europe: current community landscape and future perspectives.

Biotechnol Notes · 2022 · PMC11446344 · PMID 39416454

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a positive trendno p-value reported

There is a positive trend with European and non-European funds that have been actively investing in European synthetic biology companies; for example, investors dedicated to synthetic biology have been now created in Europe, such as eureKARE. 47 However, as already mentioned, in Europe there are not many major winners in the synthetic biology space yet.

also in 11,005 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.